Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
HIV Drugs Market Report by Drug Class (Nucleoside Reverse Transcriptase Inhibitors, Multi-Class Combination Products, Protease Inhibitors, HIV Integrase Strand Transfer Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Entry Inhibitors-CCR5 Co-Receptor Antagonist, Fusion Inhibitors and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A953
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global HIV Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Price Analysis
5.5 Market Breakup by Drug Class
5.6 Market Breakup by Distribution Channel
5.7 Market Breakup by Region
5.8 Market Forecast
5.9 SWOT Analysis
5.9.1 Overview
5.9.2 Strengths
5.9.3 Weaknesses
5.9.4 Opportunities
5.9.5 Threats
5.10 Value Chain Analysis
5.10.1 Overview
5.10.2 Research and Development
5.10.3 Raw Material Procurement
5.10.4 Manufacturing
5.10.5 Marketing
5.10.6 Distribution
5.10.7 End-Use
5.11 Porters Five Forces Analysis
5.11.1 Overview
5.11.2 Bargaining Power of Buyers
5.11.3 Bargaining Power of Suppliers
5.11.4 Degree of Competition
5.11.5 Threat of New Entrants
5.11.6 Threat of Substitutes
6 Market Breakup by Drug Class
6.1 Nucleoside Reverse Transcriptase Inhibitors
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Multi-Class Combination Products
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Protease Inhibitors
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 HIV Integrase Strand Transfer Inhibitors
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Non-Nucleoside Reverse Transcriptase Inhibitors
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Entry Inhibitors — CCR5 Co-Receptor Antagonist
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Fusion Inhibitors and Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Distribution Channel
7.1 Hospital Pharmacies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacies
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Online Pharmacies
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Latin America
8.5.1 Market Trends
8.5.2 Market Forecast
9 HIV Drugs Manufacturing Process
9.1 Product Overview
9.2 Raw Material Requirements
9.3 Manufacturing Process
9.4 Key Success and Risk Factors
10 Competitive Landscape
10.1 Market Structure
10.2 Market Breakup by Key Players
10.3 Profiles of Key Players
10.3.1 Boehringer Ingelheim International GmbH
10.3.2 Merck & Co., Inc.
10.3.3 ViiV Healthcare
10.3.4 AbbVie
10.3.5 F. Hoffmann-La Roche Ltd.
10.3.6 Teva Pharmaceutical Industries Ltd.
10.3.7 Bristol-Myers Squibb
10.3.8 Gilead Sciences, Inc.
10.3.9 Johnson & Johnson
10.3.10 Cipla Limited
10.3.11 Daiichi Sankyo
10.3.12 Emcure
10.3.13 Hetero Drugs
10.3.14 Mylan
List of Figures
Figure 1: Global: HIV Drugs Market: Major Drivers and Challenges
Figure 2: Global: HIV Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: HIV Drugs Market: Breakup by Drug Class (in %), 2023
Figure 4: Global: HIV Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 5: Global: HIV Drugs Market: Breakup by Region (in %), 2023
Figure 6: Global: HIV Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 7: Global: HIV Drugs Industry: SWOT Analysis
Figure 8: Global: HIV Drugs Industry: Value Chain Analysis
Figure 9: Global: HIV Drugs Industry: Porter’s Five Forces Analysis
Figure 10: Global: HIV Drugs (Nucleoside Reverse Transcriptase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: HIV Drugs (Nucleoside Reverse Transcriptase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: HIV Drugs (Multi-Class Combination Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: HIV Drugs (Multi-Class Combination Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: HIV Drugs (Protease Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: HIV Drugs (Protease Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: HIV Drugs (HIV Integrase Strand Transfer Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: HIV Drugs (HIV Integrase Strand Transfer Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: HIV Drugs (Non-Nucleoside Reverse Transcriptase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: HIV Drugs (Non-Nucleoside Reverse Transcriptase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: HIV Drugs (Entry Inhibitors — CCR5 Co-Receptor Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: HIV Drugs (Entry Inhibitors — CCR5 Co-Receptor Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: HIV Drugs (Fusion Inhibitors and Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: HIV Drugs (Fusion Inhibitors and Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: HIV Drugs Market: Sales through Hospital Pharmacies (in Million US$), 2018 & 2023
Figure 25: Global: HIV Drugs Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2024-2032
Figure 26: Global: HIV Drugs Market: Sales through Retail Pharmacies (in Million US$), 2018 & 2023
Figure 27: Global: HIV Drugs Market Forecast: Sales through Retail Pharmacies (in Million US$), 2024-2032
Figure 28: Global: HIV Drugs Market: Sales through Online Pharmacies (in Million US$), 2018 & 2023
Figure 29: Global: HIV Drugs Market Forecast: Sales through Online Pharmacies (in Million US$), 2024-2032
Figure 30: Global: HIV Drugs Market: Sales through Other Distribution Channels (in Million US$), 2018 & 2023
Figure 31: Global: HIV Drugs Market Forecast: Sales through Other Distribution Channels (in Million US$), 2024-2032
Figure 32: North America: HIV Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: North America: HIV Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Europe: HIV Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Europe: HIV Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Asia Pacific: HIV Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Asia Pacific: HIV Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Middle East and Africa: HIV Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Middle East and Africa: HIV Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Latin America: HIV Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Latin America: HIV Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: HIV Drugs Manufacturing: Detailed Process Flow
Figure 43: Global: HIV Drugs Market: Breakup by Key Players (in %)
List of Tables
Table 1: Global: HIV Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: HIV Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: HIV Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 4: Global: HIV Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 5: HIV Drugs Manufacturing: Raw Material Requirements
Table 6: Global: HIV Drugs Market: Competitive Structure
Table 7: Global: HIV Drugs Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More